Rebilda DC Modification
by VOCO GmbH
510(k) K060893
Active
Valid until
No date given
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK060893 | Date25 May 2006 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Full name
- Modification to Rebilda Dc
- 510(k) Number
- FDA product code
- EBF
- Device class
- Class II
- Regulation
- 21 CFR Part 872.3690
- Advisory committee
- Dental
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Rebilda DC Modification is a dental device classified under the product code EBF for dental restorative materials. It is designed as a modification to an existing dental composite system, intended for use in direct restorative procedures to repair and restore tooth structure with high precision and durability.
This modification is supplied as a dental-grade material, intended for single-use applications in clinical settings. It is authorized under FDA 510K and MDR, with a clearance type designated as Special for dental modifications. The device is supplied in sterile form and must be handled according to standard dental practice protocols to ensure proper application and patient safety.
Other devices from VOCO GmbH
Questions
AI-generated answers, 18 Sep 2026
What is the Rebilda DC Modification specifically used for in dental procedures?
The Rebilda DC Modification is a dental composite material designed for direct restorative procedures. It is intended to repair and restore damaged tooth structure with high precision and durability, filling cavities or repairing existing restorations while maintaining the integrity of the natural tooth.
Is the Rebilda DC Modification meant for single-use or can it be reused?
The Rebilda DC Modification is explicitly supplied for single-use applications in clinical settings. This ensures patient safety and sterility, aligning with standard dental practice protocols for composite materials.
How is the Rebilda DC Modification packaged and stored?
The device is supplied in a sterile form, which means it is pre-sterilized and ready for immediate clinical use. Proper storage should follow standard dental protocols to maintain sterility until use, as with other dental-grade materials.
What regulatory pathways does the Rebilda DC Modification follow?
The Rebilda DC Modification is authorized under both FDA 510K and MDR (Medical Device Regulation) frameworks. Its clearance type is designated as 'Special,' reflecting its status as a modification to an existing dental composite system, ensuring compliance with both U.S. and EU regulatory standards.